New York State Common Retirement Fund Grows Stock Holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC)

New York State Common Retirement Fund increased its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 21.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,202,334 shares of the medical technology company’s stock after purchasing an additional 210,519 shares during the period. New York State Common Retirement Fund’s holdings in Alphatec were worth $11,037,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its position in Alphatec by 11.3% during the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 2,928,094 shares of the medical technology company’s stock worth $16,280,000 after purchasing an additional 297,850 shares during the period. Barclays PLC boosted its stake in shares of Alphatec by 362.3% in the third quarter. Barclays PLC now owns 170,546 shares of the medical technology company’s stock worth $948,000 after buying an additional 133,653 shares during the last quarter. Franklin Resources Inc. grew its holdings in Alphatec by 299.3% during the third quarter. Franklin Resources Inc. now owns 64,450 shares of the medical technology company’s stock worth $343,000 after acquiring an additional 48,308 shares during the period. AlphaCentric Advisors LLC purchased a new position in Alphatec during the third quarter valued at approximately $2,057,000. Finally, Royce & Associates LP lifted its holdings in Alphatec by 15.9% in the third quarter. Royce & Associates LP now owns 1,212,286 shares of the medical technology company’s stock valued at $6,740,000 after acquiring an additional 165,954 shares during the period. 66.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Alphatec

In other news, EVP David Sponsel sold 58,283 shares of the company’s stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $10.71, for a total value of $624,210.93. Following the transaction, the executive vice president now directly owns 502,311 shares in the company, valued at approximately $5,379,750.81. This represents a 10.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Scott Lish sold 27,453 shares of the stock in a transaction that occurred on Thursday, February 6th. The stock was sold at an average price of $11.49, for a total transaction of $315,434.97. Following the transaction, the chief operating officer now directly owns 867,677 shares of the company’s stock, valued at $9,969,608.73. The trade was a 3.07 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 222,376 shares of company stock worth $2,557,148. 22.80% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ATEC has been the topic of a number of analyst reports. Barclays raised their price objective on shares of Alphatec from $20.00 to $21.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 22nd. Needham & Company LLC raised their price target on shares of Alphatec from $13.00 to $16.00 and gave the company a “buy” rating in a research report on Monday, January 13th. Finally, HC Wainwright reiterated a “buy” rating and issued a $20.00 price objective on shares of Alphatec in a research report on Tuesday, January 14th. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $17.56.

Alphatec Trading Up 1.4 %

Shares of Alphatec stock opened at $10.76 on Tuesday. The stock has a 50 day moving average of $10.50 and a 200 day moving average of $8.30. The company has a debt-to-equity ratio of 30.21, a quick ratio of 1.15 and a current ratio of 2.32. The firm has a market capitalization of $1.53 billion, a price-to-earnings ratio of -8.41 and a beta of 1.43. Alphatec Holdings, Inc. has a fifty-two week low of $4.88 and a fifty-two week high of $15.41.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.